Abstract
A series of 2,3,5-trisubstituted and 1,2,3,5-tetrasubstituted indoles is synthesized by Fisher or Bischler method, followed by alkylation with an appropriate alkyl or aryl halide. Two compounds exhibit non-competitive antagonism towards GluK1 and six – towards GluK2 receptor. The values of IC50 are in micromolar range. The investigated compounds belong to the most active GluK1 non-competitive inhibitors and are the first known negative allosteric modulators of GluK2 receptor. The observed pattern of activity is rationalized by molecular modelling, in particular by construction of the pharmacophore model.
Keywords: Allosteric modulators, Indole derivatives, Glutamate receptors, Kainate receptors, Molecular modelling, Non-competitive antagonists of kainate receptors, ionotropic glutamate receptors, Alzheimer’s disease, NMDA receptor antagonists, Zindoxifene
Letters in Drug Design & Discovery
Title:Novel Non-Competitive Antagonists of Kainate GluK1/GluK2 Receptors
Volume: 9 Issue: 10
Author(s): Agnieszka Anna Kaczor, Christiane Kronbach, Klaus Unverferth, Kalevi Pihlaja, Kirsti Wiinamaki, Jari Sinkkonen, Urszula Kijkowska-Murak, Tomasz Wrobel, Tomasz Stachal and Dariusz Matosiuk
Affiliation:
Keywords: Allosteric modulators, Indole derivatives, Glutamate receptors, Kainate receptors, Molecular modelling, Non-competitive antagonists of kainate receptors, ionotropic glutamate receptors, Alzheimer’s disease, NMDA receptor antagonists, Zindoxifene
Abstract: A series of 2,3,5-trisubstituted and 1,2,3,5-tetrasubstituted indoles is synthesized by Fisher or Bischler method, followed by alkylation with an appropriate alkyl or aryl halide. Two compounds exhibit non-competitive antagonism towards GluK1 and six – towards GluK2 receptor. The values of IC50 are in micromolar range. The investigated compounds belong to the most active GluK1 non-competitive inhibitors and are the first known negative allosteric modulators of GluK2 receptor. The observed pattern of activity is rationalized by molecular modelling, in particular by construction of the pharmacophore model.
Export Options
About this article
Cite this article as:
Anna Kaczor Agnieszka, Kronbach Christiane, Unverferth Klaus, Pihlaja Kalevi, Wiinamaki Kirsti, Sinkkonen Jari, Kijkowska-Murak Urszula, Wrobel Tomasz, Stachal Tomasz and Matosiuk Dariusz, Novel Non-Competitive Antagonists of Kainate GluK1/GluK2 Receptors, Letters in Drug Design & Discovery 2012; 9 (10) . https://dx.doi.org/10.2174/1570180811209050891
DOI https://dx.doi.org/10.2174/1570180811209050891 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanosuspension Technology For Poorly Soluble Drugs: Recent Researches, Advances and Patents
Recent Patents on Nanotechnology Sulfated Extract of <i>Abelmoschus Esculentus</i>: A Potential Cancer Chemo-preventive Agent
Current Pharmaceutical Biotechnology Antidiabetic Effect of Polyphenolic Extracts from Selected Edible Plants as α-Amylase, α -Glucosidase and PTP1B Inhibitors, and β Pancreatic Cells Cytoprotective Agents - A Comparative Study
Current Topics in Medicinal Chemistry Multi-Target Inhibitors for Proteins Associated with Alzheimer: In Silico Discovery using Fragment-Based Descriptors
Current Alzheimer Research Protein Kinase Substrate Profiling with a High-Density Peptide Microarray
Combinatorial Chemistry & High Throughput Screening Application of Novel Nanotechnology Strategies in Plant Biotransformation: A Contemporary Overview
Recent Patents on Biotechnology Folate Targeted Solid Lipid Nanoparticles of Simvastatin for Enhanced Cytotoxic Effects of Doxorubicin in Chronic Myeloid Leukemia
Current Nanoscience Design, Synthesis of Novel Quinazolone Alkaloids Derivatives as Potential Antitumor Agents
Medicinal Chemistry Pathogenesis in Childhood Idiopathic Nephrotic Syndrome: An Update of Patchwork
Current Pediatric Reviews Cancer Chemopreventive Agents Discovered by Activity-Guided Fractionation: An Update
Current Organic Chemistry Infertility, Pregnancy Loss and Adverse Birth Outcomes in Relation to Maternal Secondhand Tobacco Smoke Exposure
Current Women`s Health Reviews Copper(II) Complexes with Saccharinate and Glutamine as Antitumor Agents: Cytoand Genotoxicity in Human Osteosarcoma Cells
Anti-Cancer Agents in Medicinal Chemistry Targeted Drug Delivery: Trends and Perspectives
Current Drug Delivery Reprofiling of Troglitazone Towards More Active and Less Toxic Derivatives: A New Hope for Cancer Treatment?
Current Topics in Medicinal Chemistry Frequencies of Single Nucleotide Polymorphisms in Cytochrome P450 Genes (CYP1A2, 2A6, 2B6, 3A4 and 3A5) in a Rwandan Population: Difference to Other African Populations
Current Pharmacogenomics and Personalized Medicine Mass Spectroscopic Methods for the Characterization of Flavonoid Compounds
Current Bioactive Compounds Integrative System Biology Strategies for Disease Biomarker Discovery
Combinatorial Chemistry & High Throughput Screening How can Proteomics Reach Cancer Biomarkers?
Current Proteomics Interplay of Carotenoids with Cigarette Smoking: Implications in Lung Cancer
Current Medicinal Chemistry Antibodies in Diagnostic Applications
Current Pharmaceutical Biotechnology